SCHEMBL8249331

SCHEMBL8249331

COC(=O)c1cc(NS(=O)(=O)c2ccccc2)cc(C(=O)OC)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.70
TCF4 P15884 2/20 0.62
CTNNB1 P35222 2/20 0.62
ALDH1A1 P00352 4/20 0.58
F2 P00734 1/20 0.57
F10 P00742 1/20 0.57
FURIN P09958 1/20 0.57
CYTH2 Q99418 1/20 0.56
HTT P42858 3/20 0.55
KMT2A Q03164 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MEN1 O00255 1/20 0.55
LMNA P02545 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CRHBP P24387 1/20 0.55
CYP2C19 P33261 1/20 0.55
CRHR2 Q13324 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28543927 0.90 KDM4E (0.59) KDM4ETCF4CTNNB1ALDH1A1F2
SCHEMBL8369354 0.88 TCF4 (0.80) KDM4ETCF4CTNNB1KMT2ASMN1; SMN2
SCHEMBL25311928 0.88 ALDH1A1 (0.61) KDM4ETCF4CTNNB1ALDH1A1HTT
Phenyl(Phenylsulfonyl)Amine SCHEMBL4057888 0.86 IL1RN (0.65) KDM4ETCF4CTNNB1ALDH1A1HTT
SCHEMBL21761420 0.86 ALDH1A1 (0.69) KDM4EALDH1A1HTTKMT2ASMN1; SMN2
SCHEMBL936067 0.84 AR (0.63) KDM4ETCF4CTNNB1KMT2AMEN1
SCHEMBL10487708 0.83 WDR5 (0.73) ALDH1A1F2F10FURINCYTH2
SCHEMBL24312124 0.81 FFAR4 (0.54) KDM4ETCF4CTNNB1ALDH1A1CYTH2
SCHEMBL24102252 0.81 TCF4 (0.73) KDM4ETCF4CTNNB1ALDH1A1HTT
SCHEMBL9818397 0.80 WDR5 (0.69) ALDH1A1F2F10FURINCYTH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113817150-B Copolyester containing aromatic secondary amine structure and preparation method and application thereof 四川大学 2022-06-21 CN disclosed
CN-113817150-A Copolyester containing aromatic secondary amine structure and preparation method and application thereof 四川大学 2021-12-21 CN disclosed
US-20090042867-A1 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE FUCHS KLAUS 2009-02-12 US disclosed
US-20090042867-A1 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE FUCHS KLAUS 2009-02-12 US disclosed
WO-2007017509-A1 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042867-A1 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE PSEN1, PSEN2, MAOB KDM4E 2630/4885TCF4 3592/4885CTNNB1 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.